NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Circadian Technologies Ltd (ASX: CIR)
Â
CIR Technical Analysis
4
As on 11th Dec 2015 CIR Share Price closed @ 0.31 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.19 & Buy for SHORT-TERM with Stoploss of 0.25 we also expect STOCK to react on Following IMPORTANT LEVELS. |
Â
Â
CIR Share Price
Open | 0.30 | Change | Price | % |
High | 0.31 | 1 Day | 0.00 | 0.00 |
Low | 0.30 | 1 Week | 0.00 | 0.00 |
Close | 0.31 | 1 Month | 0.00 | 0.00 |
Volume | 70000 | 1 Year | 0.00 | 0.00 |
52 Week High 33.50 | 52 Week Low 30.51 |
Â
ASX Australia Most Active Stocks
COE | 0.30 | 3.45% |
GPP | 0.02 | 0.00% |
DUE | 3.02 | 1.00% |
BUR | 0.02 | 0.00% |
AGO | 0.02 | 0.00% |
BPT | 1.05 | 7.14% |
PNX | 0.01 | 0.00% |
PIO | 0.03 | 0.00% |
DJS | 3.99 | 0.00% |
KSO | 0.40 | 3900.00% |
Â
ASX Australia Top Gainers Stocks
Â
ASX Australia Top Losers Stocks
Â
Â
CIR Daily Charts |
CIR Intraday Charts |
Whats New @ Bazaartrend |
CIR Free Analysis |
|
Â
CIR Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
RESISTANCE | 0.32 |
RESISTANCE | 0.32 |
SUPPORT | 0.30 |
SUPPORT | 0.30 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
Â
CIR Target for Month April
4th UP TARGET | 0 |
3rd UP TARGET | 0 |
2nd UP TARGET | 0 |
1st UP TARGET | 0 |
1st DOWN TARGET | 0 |
2nd DOWN TARGET | 0 |
3rd DOWN TARGET | 0 |
4th DOWN TARGET | 0 |
Â
CIR Weekly Target
4th UP TARGET | 0.00 |
3rd UP TARGET | 0.00 |
2nd UP TARGET | 0.00 |
1st UP TARGET | 0.00 |
1st DOWN TARGET | 0.00 |
2nd DOWN TARGET | 0.00 |
3rd DOWN TARGET | 0.00 |
4th DOWN TARGET | 0.00 |
Â
CIR Target for Year 2021
4th UP TARGET | 0 |
3rd UP TARGET | 0 |
2nd UP TARGET | 0 |
1st UP TARGET | 0 |
1st DOWN TARGET | 0 |
2nd DOWN TARGET | 0 |
3rd DOWN TARGET | 0 |
4th DOWN TARGET | 0 |
Â
Circadian Technologies Ltd ( ASX Australia Symbol : CIR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
Â
CIR Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers - Major | |
Offical website | > |
Â
CIR Address
![]() |
650 Chapel Street Suite 0403 South Yarra, VIC 3141 Australia Phone: 61 3 9826 0399 Fax: 61 3 9824 0083 |
Â
CIR Latest News
Â
Â
CIR Business Profile
Circadian Technologies Limited develops and commercializes therapies for cancer and eye diseases in Australia. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and R3 targets. The company’s product pipeline includes anti-VEGFR-3 antibody that is in Phase I clinical trials for the treatment of solid tumours; VGX-100, a human antibody against VEGF-C, as a treatment for lymphedema resulting from breast cancer treatment and solid tumours; and VGX-300, a soluble form of VEGFR-3 for ‘back of the eye’ disease. It also develops diagnostic test products for cancers of unknown primaries; and blood based diagnostic tests for VEGF-C and VEGF-D as predictive and prognostic tests in lymphangioleiomyomatosis and cancer patients. The company is based in South Yarra, Australia.
Â
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service